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Abstract 
Genetic and molecular studies have implicated the Bromodomain containing 1 (BRD1) gene in the 
pathogenesis of schizophrenia and bipolar disorder. Accordingly, mice heterozygous for a targeted 
deletion of Brd1 (Brd1
+/-
 mice) show behavioral phenotypes with broad translational relevance to 
psychiatric disorders. BRD1 encodes a scaffold protein that affects the expression of many genes through 
modulation of histone acetylation. BRD1 target genes have been identified in cell lines; however the 
impact of reduced Brd1 levels on the brain proteome is largely unknown. In this study, we applied label-
based quantitative mass spectrometry to profile the frontal cortex, hippocampus and striatum proteome 
and synaptosomal proteome of female Brd1
+/-
 mice. We successfully quantified between 1537 and 2196 
proteins and show widespread changes in protein abundancies and compartmentalization. By integrative 
analysis of human genetic data, we find that the differentially abundant proteins in frontal cortex and 
hippocampus are enriched for schizophrenia risk further linking the actions of BRD1 to psychiatric 
disorders. Affected proteins were further enriched for proteins involved in processes known to influence 
neuronal and dendritic spine morphology e.g. regulation of cytoskeleton dynamics and mitochondrial 
function. Directly prompted in these findings, we investigated dendritic spine morphology of pyramidal 
neurons in anterior cingulate cortex and found them significantly altered, including reduced size of small 
dendritic spines and decreased number of the mature mushroom type. Collectively, our study describes 
known as well as new mechanisms related to BRD1 dysfunction and its role in psychiatric disorders, and 
provides evidence for the molecular and cellular dysfunctions underlying altered neurosignalling and 
cognition in Brd1
+/-
 mice. 
Keywords: Dendritic spine, cytoskeleton, proteomics, TMT10plex, bromodomain containing 1, 
animal model, schizophrenia, mitochondria. 
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Abbreviations:  
BD: bipolar disorder; BH: Benjamini-Hochberg; DAP: differentially abundant protein; DCP: 
differentially compartmentalized protein; FDR: false-discovery rate; LD: linkage disequilibrium; LFC: 
log2 fold change; GWAS: genome-wide association study; IAA: 2-Iodoacetamide; MS: mass 
spectrometry; SZ: schizophrenia; TCEP: tris(2-carboxyethyl)phosphine; FrC: frontal cortex; HC: 
hippocampus; ST: striatum; WT: wild type; Cell: cell lysate; Syn: synaptosome; LTP: long term 
potentiation; LTD: long term depression 
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Introduction 
Repeated evidence from large genetic studies have implied that the bromodomain containing 1 (BRD1) 
gene has a role in susceptibility to schizophrenia (SZ) and possibly also to bipolar disorder (BD) 
1–8
. The 
SZ risk allele of the BRD1 promoter SNP rs138880 and SNPs in high linkage disequilibrium (LD) have 
been shown to be correlated with reduced BRD1 mRNA expression 
9
 as well as increased DNA 
methylation of the BRD1 promoter 
10
, suggesting that reduced BRD1 expression might contribute to 
increase  SZ risk. This is further indicated, by the identification of a SZ case with a disruptive nonsense 
mutation in BRD1 
4
, even though BRD1 is otherwise highly intolerant to loss of function mutations 
11
. 
BRD1, which is a scaffold protein that interacts with histone modifiers and chromatin remodelling 
proteins 
12,13
, seems to be functionally interconnected with a large number of schizophrenia risk genes by 
means of direct protein-protein interactions 
12
 as well as by its genomic binding sites 
12
 and gene 
regulatory effects 
9,12,14
. The expression of BRD1 itself is highly regulated during brain development 
2
 and 
stem cell differentiation 
15
 as well as by environmental stimuli like chronic restraint stress 
16
, 
electroconvulsive seizures 
17
 and commonly used mood stabilizers 
10
. Underlining the impact of BRD1 on 
mental health, mice with a monoallelic inactivation of Brd1 (Brd1
+/-
 mice) are characterized by 
behavioral-, neuromorphological and neurochemical changes with broad translational relevance to 
psychiatric disorders 
9,14,18,19
. In female Brd1
+/-
 mice, this includes reduced cortical serotonin, despair-like 
behaviors, impaired pre-attentive processing and neurocognitive deficits accompanied by aberrant 
morphology of pyramidal neurons and reduced dendritic spine density in anterior cingulate cortex (aCC) 
14,18
. Furthermore, genomic and transcriptomic studies have revealed that BRD1 might act as a modulator 
of nuclear receptor mediated signaling, which may explain sex-biased symptom profiles 
12,14
. Although, 
expression profiles have been generated by RNAseq for selected brain regions to characterize molecular 
signatures in Brd1
+/-
 mice 
9,14
, the effects of BRD1 deficiency on protein abundancies in the brain remains 
largely unknown. Here, we thus investigated the brain proteome in Brd1
+/-
 mice using quantitative mass 
spectrometry (MS) and labelling with isobaric tags (Tandem Mass Tags, TMT). We set out to map the 
proteome composition of three different brain regions: frontal cortex (FrC), hippocampus (HC) and 
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striatum (ST), and additionally applied synaptosomal proteomics of the same tissues to further decipher 
differences in protein abundancy and cellular compartmentalization caused by BRD1 deficiency in the 
brain. Our findings are followed up by integrative analyses using human genetic data and detailed 
analysis of dendritic spine morphology in mice.  
Materials and Methods 
Animals 
Brd1
+/-
 mice are heterozygous for an inactivated allele of Brd1 
9
. Female Brd1
+/-
 and wild type (WT) 
littermates were sacrificed at age 6-8 weeks by cervical dislocation and brain tissues (frontal cortex, 
hippocampus and striatum) were collected by free-hand dissection, snap frozen and stored at -80°C upon 
further use (Suppl. Information 1). All studies were carried out in accordance with Danish legislation, 
granted by the animal welfare committee, appointed by the Danish Ministry of Food, Agriculture and 
Fisheries – Danish Veterinary and Food Administration. 
Protein Isolation 
Brain regions were homogenized using pestles from the Grinding Kit (GE Healthcare, Chicago, Illinois, 
USA) in core buffer as previously described 
20
 supplemented with 1 Complete Mini Protease Inhibitor 
Cocktail tablet (Roche, Penzberg, Germany) per 10 ml buffer. The homogenate was split in two fractions 
for total cell lysate and for enrichment of synaptosomes, respectively. The total cell lysate was prepared 
by two repeated freeze-thaw cycles, bath sonication and centrifugation at 12000 rpm for 5 min. The 
supernatant was isolated and stored at -20°C upon further use. The synaptosomal fraction was prepared as 
described before with minor adaptations 
20
. In short, the homogenate was filtered through a 5 µm 
membrane (Millipore, Billerica, Massachusetts, USA). Thereafter the flow-through was centrifuged to 
pellet the synaptosomal fraction. The frontal cortex samples for MS analysis were redissolved in core 
buffer. The frontal cortex (for validation), hippocampal and striatal samples were redissolved in 0.1% 
SDS in core buffer and sonicated at maximum intensity for 1 min. Total protein concentration of all 
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fractions was measured with the Fluoroprofile Protein Quantification Kit (Sigma Aldrich, St. Louis, 
Missouri, USA) according to manufacturer’s recommendations. 
Western Blotting Analysis 
Protein samples were diluted to 2.5 mg/ml in reducing loading buffer (Life Technologies, Waltham, 
Massachusetts, USA), boiled at 95°C for 10 min and loaded on a Criterion™ TGX Stain-Free™ SDS 
PAGE gel (Biorad, Hercules, California, USA). After size separation, the gel was activated for 4 min 
under UV light. The proteins were then transferred to a low fluorescence PVDF membrane (Biorad). The 
membrane was blocked in 10% skimmed milk buffer (Millipore) and incubated with one of the following 
primary and appropriate secondary antibodies: anti-beta actin (Abcam, Cambridge, United Kingdom, 
#ab6276, 1:25000), anti-PSD95 (Millipore #MAB1596, 1:700), anti-VDAC1 (Abcam #ab15895, 
1:25000), anti-GAP43 (Santa Cruz, Dallas, Texas, USA #SC10786, 1:1000), anti-HSP60 (Sigma Aldrich, 
#H3524, 1:25000), anti-NDUFA9 (Mitoscience, Eugene, Oregon, USA, #MS111, 1:25000), anti-NF200 
(Sigma Aldrich, #N4142, 1:1000), anti-GFAP (Sigma Aldrich, #G3893, 1:10000), goat anti-rabbit 
antibody (Dako, Glostrup, Denmark, #P0448), and goat anti-mouse antibody (Dako, #P0447). The 
membrane was developed with Pierce ECL Plus Western Blotting Substrate (Thermo Scientific, 
Waltham, Massachusetts, USA) and visualized with Image Quant LAS-4000 Imager (GE Healthcare). 
Antibody sensitivity was tested for by checking for linear response to increased protein amounts (standard 
curve from a pool of all samples, four points between 12.5 and 50 µg total protein loaded). Protein 
abundances of samples within an extrapolated range of the standard curve (±7 µg of the most extreme 
points from the standard curve) were calculated based on the standard curve and normalized to total 
protein intensity of transferred proteins (minimum 3 samples per group). 
Sample Preparation for Mass Spectrometry 
Protein samples were prepared for labelling by TMT10plex Mass Tag Labelling (Thermo Scientific) 
according to the manufacturer’s protocol. In short, 100 μg of total protein was reduced and alkylated with 
tris(2-carboxyethyl)phosphine (TCEP) and 2-Iodoacetamide (IAA), followed by overnight acetone 
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precipitation. After redissolving the pellet, proteins were digested overnight with trypsin (Promega, 
Fitchburg, Wisconsin, USA). Resulting peptides were labelled with the TMT10plex Mass tags and the 10 
samples were pooled. Labelled peptide pools were dissolved in 0.1% formic acid pH 2.3, before being 
fractioned into 8 fractions using Oasis MCX µElution (Waters Corporation, Milford, Connecticut, USA). 
Peptides were stepwise eluted in seven 50 mM ammonium formate buffers, containing 15% (first eluate) 
or 35% (all other eluates) methanol and with acidity ranging between pH 2.6 and pH 9. The final fraction 
was eluted with a buffer containing 35% methanol and 5% NH4OH. 
NanoLC-MS/MS 
Liquid chromatography tandem mass spectrometry (LC-MS/MS) was performed on an EASY nanoLC-
1000 coupled to Q Exactive™ Plus Hybrid Quadrupole-Orbitrap™ Mass Spectrometer (Thermo 
Scientific). TMT tagged peptide samples were trapped on a pre-column (PepMap 100, C18, 2 cm, 75 µm 
i.d., 3µm, 100 Å, Thermo Scientific) followed by separation on a C18 reverse phase column with 
integrated emitter (EASY-Spray column, Plug and spray, PepMap 25 cm, 75 μm i.d., 2 μm, 100 Å, 
Thermo Scientific). Separation was conducted using Buffer B containing 90/10 acetonitrile/water and 
0.1% formic acid at a flowrate of 300 nL/min in a 90 minute linear gradient (4 to 40% Buffer B). The MS 
was operated in a positive data dependent mode, automatically switching between MS1 (full scan) and 
MS2 (fragmentation scan) acquisition. Resolution of MS1 was set to 70000 and MS2 to at least 35000. In 
MS1, AGC target was set to 1x10
6
 ions and scan range between 380-1800 m/z. In MS2, AGC target was 
set at 2x10
5
 ions, with fixed first mass set to 120 m/z. Dynamic exclusion was set to 20 sec, isolation 
window at 2.0 m/z,  and up to ten of the most intense ions were fragmented after every MS1 scan, by 
higher-energy C-trap dissociation (HCD). Ions with single charge or unassigned charge states were 
excluded from fragmentation.  
 LC-MS/MS analyses were performed three times for each peptide sample, with the third analysis 
applying an exclusion list of the 100 most intense peptide peaks. All three LC-MS analyses of the same 
sample set were merged and submitted to database searches for protein identification and quantification.  
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Data Analysis 
Peptide identification was performed in Proteome Discoverer 1.4 (Thermo Scientific) using the Mascot 
(Matrix Science, Boston, Massachusetts, USA) database algorithm and the Percolator algorithm 
21
, with 
UniProt Knowledgebase release 2014_10 (Number of sequences after taxonomy (Mus musculus): 16 693) 
as reference proteome. The following settings were applied: total intensity threshold of 20000; precursor 
mass tolerance of 7 ppm; fragment mass tolerance of 10 mmu; peak integration tolerance of 10 ppm; 
minimum MS/MS peak count of 20; maximum 2 missed trypsin cleavages allowed. Only protein-unique 
peptides with FDR <0.01 and co-isolation <40% were included in the analysis. Proteins with at least 2 
unique peptides and minimum 3 scans were considered for quantification. Raw peptide intensities were 
normalized using LOESS regression (0.4 window width) in the InfernoRDN software
22
. Protein 
abundances were then obtained by the RRollup algorithm
22
. Differentially abundant proteins (DAPs) were 
identified by PLGEM 
23,24
. Log2 fold change (LFC) cut-off was set as two times the global standard error 
of the mean of the dataset. Proteins were considered differential abundant between Brd1
+/-
 and WT mice 
if both p < 0.05 and LFC > cut-off value. Proteins were considered as ‘top DAPs’ when p < 0.001 and 
LFC > cut-off. To identify differentially compartmentalized proteins (DCPs), the synaptosome-to-cell 
lysate abundancy ratio was calculated for all proteins detected in both datasets from the same brain 
region. Ratios were compared between genotypes using PLGEM. Proteins are considered DCPs when 
p<0.05.  
Mitochondrial proteins were selected according to Pagliarini et al. with a cut-off threshold corrected false 
discovery rate (cFDR) set at 7% according to previously reported research 
25
 and to MitoMiner with 
positive score in at least 4 of the evidence lines 
26
. Mouse protein IDs were converted to the human 
homologue Ensembl Gene ID for bioinformatic analysis using the db2db online tool 
27
. DAVID 
bioinformatics tools were used for Functional Annotation Clustering
28
  with standard settings and using 
all identified proteins of the specific brain region as background. Protein-protein interaction network 
analysis was performed using the STRING database employing standard settings 
29
. Enrichment analysis 
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for transcription factor binding was performed using Enrich
30
 (ENCODE and ChEA Consensus TFs from 
ChIP-X) using default settings. Risk gene enrichment analysis was performed using MAGMA 
31
 with 
default settings and using all identified proteins of the specific brain region as background. The analysis 
was based in summary statistics from single-marker genome-wide association studies (GWASs) 
8,32–38
 
(excluding the broad MHC region (chr6: 25 M-35 M)) and filtered for info score ≥0.8 if available. Genes 
were annotated using Ensemble (GRCh38.p12). Information about linkage disequilibrium was obtained 
using the 1000 Genomes European panel 
39
.  
Availability of data 
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the 
PRIDE partner repository with the dataset identifier PXD009688; PXD009689; PXD009690; 
PXD009691; PXD009692; PXD009961. 
Dendritic Spine Morphology  
Dendritic spine morphology analysis was performed using the Golgi-cox stained brain slices derived from 
an independent set of mice and 3D reconstructed pyramidal neurons described previously (Suppl. 
Information 1) 
14
. Identification and analysis of dendritic spines was done with IMARIS 7.7.1 software. 
Classification of spine types was done with following settings: Stubby (length < 1 µm), Mushroom 
(length < 3 µm and max diameter (head) > 2x mean width (neck)), Long Thin (mean width (head) ≥ mean 
width (neck)), and Filopodia / Dendrite (rest).  
Continuous parameters were analyzed using a linear mixed-effects model (lmer function in the R package 
lme4 
40
), binary parameters were analyzed using a generalized linear mixed-effects model (glmer function 
in the R package lme4 
40
) as previously described 
41
. All models included spine level and depth (as 
defined by IMARIS) and genotype as explanatory variables, and neuron and mouse as level identifiers. 
Significance testing of contribution of parameters was conducted using the lmerTest package in R 
40
 and 
BH correction was applied to correct for multiple testing.  
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Results 
BRD1 deficiency is associated with widespread changes in protein abundancies in brain  
To discover novel BRD1 dependent molecular changes in the brain, we profiled differentially abundant 
proteins (DAPs) in three brain regions which show differential neurochemistry and mRNA expression 
levels and which are involved in observed behavioral changes in female Brd1
+/- 
mice 
14,18
: frontal cortex 
(FrC), hippocampus (HC) and striatum (ST). By subjecting total cell lysates (Cell) and extracts enriched 
for synaptosomes (Syn) to MS-based quantitative proteomics using TMT10plex (Figure 1) we obtained 
six protein datasets (FrC-cell, FrC-syn, HC-cell, HC-syn, ST-cell, and ST-syn) (Suppl. Information 2, 
Suppl. Figure 2). All datasets were checked for gross differences in cell composition using cell type 
specific markers and one sample from FrC-Syn was removed from further analysis due to an apparent 
diverging proportion of oligodendrocytes (Suppl. Information 2, Suppl. Figure 2). We observed a shift 
in the mitochondrial subproteome (69/234 (29%) detected mitochondrial proteins are identified as DAPs, 
of which 66 are downregulated in Brd1
+/-
 mice compared to WT) in the FrC-syn dataset, which was 
subsequently removed to avoid bias in normalization (Suppl. Information 3, Suppl. Figure 4). Overall, 
we detected 1880 unique proteins in FrC (both datasets combined), 2370 unique proteins in HC (both 
datasets combined) and 1978 unique proteins in ST (both datasets combined) (Suppl. Table 2). Because 
no protein remained significant after BH-correction for multiple testing in any of the datasets, we 
classified 16 proteins as ‘top DAPs’ (Figure 2 and Table 1). These top DAPs could be categorized in six 
groups based on function (Figure 2 and Table 1): Transcription & chromatin (6 top DAPs), neuronal 
morphology and growth (4 top DAPs), cellular transport (2 top DAPs), neuroendocrine (2 top DAPs), and 
other (2 top DAPs). We selected 4 proteins from frontal cortex for validation by Western blotting analysis 
in an independent set of samples: 3 mitochondrial proteins (VDAC1, HSP60 and NDUFA9) and GAP43. 
After exclusion of HSP60 for technical reasons, we were able to confirm the differential abundancies of 2 
out of the 3 remaining proteins (NDUFA9 and GAP43) (Suppl. Information 4). Additionally, we found 
significantly less PSD95 in Brd1
+/-
 mice in FrC-syn (LFC=-0.10, p=0.0480). This is in line with 
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previously observed reduced dendritic spine density in anterior cingulate cortex (aCC), 
14
 thereby further 
validating our findings.
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Figure 1: Overview of the sample preparations and MS pipeline. Abbreviations: wild type (wt); female heterozygous Brd1 knockout mice (Brd1
+/-
); frontal cortex (FrC); hippocampus (HC); striatum (ST); cell lysate (cell); synaptosome (syn); mass spectrometry (MS); mixed-mode cationic 
exchange (MCX); nano liquid chromatography – tandem mass spectrometry (nanoLC-MS/MS); quality control (QC); not significant (ns); 
differentially abundant proteins (DAPs); top differentially abundant proteins (top DAPs).  
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Figure 2: A) Total number of unique proteins detected in female Brd1
+/- 
mouse brain regions. 
Differentially abundant proteins (DAPs, p<0.05 and LFC > cut-off); top differentially abundant proteins 
(Top DAPs p<0.001 and LFC > cut-off). LFC cut-off: ±0.231 (FrC-Cell), ±0.104 (FrC-Syn), ±0.099 
(FrC-Syn (excl mito)), ±0.191 (HC-Cell), ±0.072 (HC-Syn), ±0.189 (ST-Cell), ±0.102 (ST-Syn). B) Total 
number of unique proteins shared between cell lysate and synaptosomal preparations of the same brain 
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region and differentially compartmentalized proteins (DCPs, p<0.05). C) Distribution of the proteins 
among fractions and statistical significant groups.  Abbreviations: frontal cortex (FrC); hippocampus 
(HC); striatum (ST); cell lysate (cell); synaptosome (syn); not significant (ns). 
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Table 1: Overview of the top differential abundant proteins (top DAPs) detected in female Brd1
+/- 
mouse 
brain.  
UniProt Entry 
Name
1 
Gene 
Symbol 
UniProt Protein Name P-
value 
LF
C 
Datas
et 
Transcription & chromatin  
TB182_MOUSE Tnks1bp1 182 kDa tankyrase-1-binding protein 0.0003 0.70 Frc-
cell 
TMA7_MOUSE Tma7 Translation machinery-associated protein 
7 
0.0003 0.93 Frc-
cell 
TCAL5_MOUSE Tceal5 Transcription elongation factor A protein-
like 5 
0.0004 1.05 Frc-
cell 
HMGN1_MOUSE Hmgn1 Non-histone chromosomal protein HMG-
14 
0.0005 0.82 Frc-
cell 
T22D1_MOUSE Tsc22d1 TSC22 domain family protein 1 0.0005 0.92 Frc-
cell 
CNBP_MOUSE Cnbp Cellular nucleic acid-binding protein 0.0010 0.75 Frc-
cell 
Cellular transport 
SYNRG_MOUSE Synrg Synergin gamma 0.0008 0.79 Frc-
cell 
MON2_MOUSE Mon2 Protein MON2 homolog 0.0006 0.53 HC-
syn 
Neuroendocrine 
CMGA_MOUSE Chga Chromogranin-A 0.0004 1.05 Frc-
cell 
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PENK_MOUSE Penk Proenkephalin-A 0.0004 0.85 Frc-
cell 
Neuronal morphology and growth 
OGFR_MOUSE Ogfr Opioid growth factor receptor 0.0005 0.93 Frc-
cell 
S10A5_MOUSE S100a5 Protein S100-A5 0.0007 -
0.67 
Frc-
syn 
MT3_MOUSE Mt3 Metallothionein-3 0.0008 1.07 Frc-
cell 
NEUM_MOUSE Gap43 Neuromodulin 0.0002 0.47 Frc-
syn 
Other 
PTMA_MOUSE Ptma Prothymosin alpha 0.0005 1.12 Frc-
cell 
PRC2C_MOUSE Prrc2c Protein PRRC2C 0.0007 0.56 Frc-
cell 
1. The listed proteins passed the criteria of both p<0.001 and log2 fold change (LFC > cut-off). 
LFC: log2 fold change compared to WT mice. Abbreviations: frontal cortex (FrC); hippocampus 
(HC); striatum (ST); cell lysate (cell); synaptosome (syn). 
DAPs are interconnected and cluster in functions related to mitochondria and the cytoskeleton  
To inform about a potential biological role of the DAPs, we first performed a protein-protein interaction 
(PPI) enrichment score analysis using the STRING algorithm (Suppl. Information 5). DAPs in all brain 
regions, except HC-cell were significantly enriched for PPIs, with enrichment ratios ranging from 3.31 
(FrC-cell) to 26.14 (ST-cell), meaning that DAPs within these datasets are at least partly biologically 
interconnected. The lack of significant results among DAPs from HC-cell is likely due to the lack of 
power as a result of the low number of DAPs (n = 18) in this dataset.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
Next, in order to gain more insight into associated functions, we performed DAVID Functional 
Annotation Clustering analysis. We found eight clusters significantly enriched in ST-cell, five in FrC-cell 
and three in ST-syn (Suppl. Table 5). Five of the ST-cell clusters are related to mitochondria 
(Enrichment Scores between 10.42 and 2.1).Two of the FrC-cell cluster are related to the proteasome 
(Enrichment Scores 4.5 and 1.7). Among the other enriched cluster are calmodulin-binding, microtubule, 
and synapse.  
Subsequently, in order to investigate the underlying mechanism and cascades that may explain the 
observed DAPs, we tested whether the genes encoding DAPs were enriched for transcription factor 
binding. We found enrichment for 33 unique transcription factors (Suppl. Table 6). Six of the 
transcription factors are enriched more than once: TAF1 (FrC-cell and HC-syn), ATF2 (FrC-cell and HC-
syn), CEBPD (FrC-cell amd HC-syn), NELFE (Frc-cell and HC-syn), PBX3 (FrC-cell and HC-syn) and 
REST (FrC-cell, ST-cell and ST-syn).  
DAPs are enriched for schizophrenia risk 
We hypothesized that DAPs, like BRD1 target genes and differentially expressed genes in mouse brains 
9,12,14
, are enriched for psychiatric disorder risk genes. Because the strongest evidence for genetic 
association is found between SZ and BRD1, we first tested whether DAPs are enriched for SZ risk using 
MAGMA 
31
. We found that DAPs from FrC-cell and HC-cell are significantly enriched for SZ risk (pFrC-
cell=0.049 and pHC.cell=2.6E-5) (Figure 3). Next, we investigated the enrichment of for mental health risk 
genes among DAPs, testing 7 other GWAS datasets, comprising 5 psychiatric disorders and 2 unrelated 
phenotypes (Suppl. Information 6).  
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Figure 3: MAGMA disease risk enrichment analysis for schizophrenia. Black dashed line: significance 
threshold (p=0.05). Abbreviations: frontal cortex (FrC); hippocampus (HC); striatum (ST); cell lysate 
(cell); synaptosome (syn). 
BRD1 deficiency is associated with differential protein compartmentalization  
Next we wondered whether we could identify differences in protein abundancy between the cell lysate 
and synaptosomal preparations, indicating that certain proteins are affected by processes such as 
trafficking or local protein degradation resulting in differential compartmentalization. To do so, we 
calculated the synaptosome-to-cell lysate abundancy ratio (syn/cell) for all proteins detected in both 
datasets from the same region (nFrC=1054, nHC=1586, nST=1308) and compared these ratios between 
genotypes (Figure 2B and 2C). We identified 48, 5 and 104 differentially compartmentalized proteins 
(DCPs) in FrC, HC and ST, respectively, when comparing genotypes (Suppl. Table 7). The vast majority 
of these (40/48 in FrC, 3/5 in HC and 99/104 in ST) of these have a negative LFC, indicating that these 
proteins are relatively less abundant in synaptosomal preparations compared to cell lysate in Brd1
+/- 
mice. 
In line with this finding, several of the DCPs had been identified as DAPs (Figure 2C). In FrC, 39 DCPs 
were also DAPs (37 upregulated) in cell lysate, and 7 were DAPs (5 downregulated) in synaptosome. 
Among the 5 DCPs in HC, we identified 1 DAP (upregulated) from cell lysate and 3 DAPs (1 
downregulated) from synaptosome. In ST, 56 DAPs (54 upregulated) from cell lysate were among the 
DCPs, and 11 (6 downregulated) from synaptosome. We then used DAVID Functional Annotation 
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Clustering analysis to identify the function of DCPs. This analysis revealed 1 cluster (enrichment score = 
2.0) related to calcium signaling among DCPs in FrC, none in HC and 10 enriched clusters among DCPs 
in ST (enrichment scores between 1.4 and 13.7). Eight out of ten DCP clusters in ST were related to 
mitochondria.  
BRD1 deficiency is associated with changes in dendritic spine morphology 
We note that recurrent results point in the direction of aberrant neuromorphology in Brd1
+/-
 mice: 1) Four 
top DAPs (OGFR, S100A5, MT3, GAP43) in this study have a function related to neuronal morphology 
and growth 2) DAVID cluster analysis of DAPs showed “microtubule” among the enriched clusters for 
the FrC-cell dataset, including DAPs like Tau, Microtubule-associated Protein 4 (MAP4) and 
Microtubule-associated protein 2 (MAP2); microtubule dynamics have been shown to influence dendritic 
spine morphology 
42,43
 and 3) We have previously reported altered morphology of pyramidal neurons in 
the aCC of female Brd1
+/-
 mice 
14
. We hypothesized here that dendritic spine morphology in addition is 
altered in Brd1
+/-
 mouse brain, and performed a morphology analysis of dendritic spines derived from 
aCC pyramidal neurons.  
We first classified the spines into 4 classes (stubby, mushroom, long thin and filopodia) and observed an 
overall difference in distribution between genotypes (Chi square test, p < 0.001) (Figure 4A). This 
overall difference seems to be driven by a loss of mushroom types (-5.2%) and a gain of stubby type 
spines (+4.3%) in Brd1
+/-
 mice. To determine the underlying differences between genotypes that cause 
this class shift, we measured spine length, area, volume, minimum and maximum diameter for the whole 
dendritic spine as well as for the subparts spine head, neck and ground (the subparts not for spine area) 
from the same dendritic spines. After correcting for multiple testing, we found that dendritic spines from 
Brd1
+/-
 mice were smaller with respect to minimum (total spine, padjusted < 0.0001, βlogodds = -28.8 ± 2.1) 
and maximum (total spine, padjusted = 0.01216, βlogodds = -4.8 ± 1.5) diameter for the total spine, spine head, 
neck and ground (Figure 4B, 4C, and Suppl. table 8). The observed differences in maximum diameter 
and maximum ground diameter was found in the smaller subpopulation (spines with diameter ≤ 234.0 
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nm), but not in the larger subpopulation (Suppl. table 8). Additionally, spines with length < 1.2 µm were 
significantly smaller in Brd1
+/- 
mice (padjusted = 0.01391, β = -48.3 ± 16.6 nm) (Figure 4D). Figure 4E 
illustrates and summarizes the effects of reduced Brd1 levels on pyramidal neuron spine morphology in 
aCC.  
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Figure 4: Analysis of dendritic spine morphology in aCC pyramidal neurons. A) Relative distribution of 4 dendritic spine types. B) Comparison of 
relative frequency per genotype of maximum diameter of dendritic spines per category (category 1: maximum spine diameter < 11 7.0 nm, 
category 2: 117.0 nm ≤ maximum spine diameter) between wild type (n=27182) and Brd1+/- (n=11820) spines. P-value as determined using a 
generalized linear mixed-effect model. C) Comparison of relative frequency of minimum diameter of dendritic spines per category (category 1: 
minimum spine diameter < 117.0 nm, category 2: 117.0 nm ≤ minimum spine diameter ≤ 234.0 nm) between wild type and Brd1+/- dendritic 
spines. P-value as determined using a generalized linear mixed-effect model. D) Comparison of the cumulative frequency of spine length between 
wild type and Brd1
+/-
 spines. P-value as determined using a linear mixed-effect model. Small spines are defined as spines with spine length < 1.2 
µm. E) Overview of measured parameters and comparison between dendritic spines derived from wild  type and Brd1
+/-
 mice. Dotted line 
represents parameters with a significant difference between genotypes. Ns: not significant, * p < 0.05, **** p < 0.001.  
 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
Discussion 
In this study, we use proteomic profiling to demonstrate widespread changes in protein abundancies and 
compartmentalization in brain regions of female Brd1
+/-
 mice. We found that affected proteins are highly 
interconnected and they cluster in functions related to transcription and chromatin, in line with the 
putative role of BRD1 as a scaffold protein in HAT complexes
12,13
, as well as mitochondria and the 
cytoskeleton. Directly based on these findings, we studied dendritic spines in aCC and found evidence of 
aberrant morphology. Upstream of DAPs, we found enrichment for several transcription factors. In line 
with the current and previous findings that proteins important for mitochondrial function are regulated 
upon reduced BRD1 levels in mouse brain regions 
14
, the PPARD transcription factor is involved in the 
nuclear control of proteins important for mitochondrial function. Of specific interest with respect to 
previous findings are CREB1 and SMAD4, the latter found in complexes with among others c-FOS. In 
male Brd1
+/-
 mice, CREB has been identified as an likely upstream regulator of differentially expressed 
genes in striatum and aCC and has been found hyperphosphorylated in whole brain extracts 
9
. Its 
transcriptional target, c-FOS, was furthermore significantly more abundant in the same samples 
9
. Of 
special note, we found enrichment for schizophrenia risk among identified DAPs in frontal cortex and 
hippocampus further supporting the functional link between BRD1 and schizophrenia risk genes 
9,12,14
. In 
close analogy to the experimental setup in the present study, review-analyses of proteomic studies of post-
mortem brain tissue from patients with SZ and BD have further revealed that, indifferent for the used 
platform or studied brain region, mitochondrial and cytoskeletal components are consistently dysregulated 
44–46
.  
Previously we have shown that the reduced expression of Brd1 leads to phenotypes with translational 
relevance to SZ in mice, including many aspects from positive, negative and cognitive symptoms 
9,14,18
. In 
the present study, we profiled BRD1 dependent changes in protein abundancies and compartmentalization 
in mouse brain to further decipher the potential impact of its deficiency. Proteomic profiles represent the 
true state of the cell better than transcriptomic profiles, as they assess the final sum of protein synthesis, 
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degradation and localization. On the other hand, researchers in proteomics have to compromise between 
sensitivity and risk for false positives, therefore tending to be rather conservative, and face limited 
coverage of low abundant proteins 
47
 and limited sample size in the case of quantification based on 
isobaric labelling. To deal with low coverage, we employed the combination of distinct sample 
preparation, each enriching for proteins from different cell compartments, as well was repeated 
measurement of the same samples with different LC-MS/MS settings. To avoid false positives, we 
employed a rather conservative approach during QC, only including MS scans, peptides and proteins with 
sufficient evidence in the final datasets.  
Both cytoskeleton dynamics and mitochondria are known to influence neuronal and dendritic spine 
morphology. Firstly, spine morphology is regulated tightly by both the F-actin and microtubule network. 
F-actin is mostly located within the spine, whereas microtubule provide a dynamic support for transport 
both long-distance and activity-dependent transport of cargoes in and out the spine 
43
. Inadequate 
functioning of the cytoskeleton dynamics could lead to aberrant spine morphology and to disease. For 
example, drug-induced destabilization of microtubule modulated spine morphology from the mature 
mushroom-type into the immature filopodia-type 
48
, knockout of PAR1B in mice reduced the number of 
mature spines and induced spatial memory formation 
49
. Furthermore, decreased immunoreactivity of 
MAP2 has been repeatedly shown in post-mortem brains from SZ patients and is associated with reduced 
spine density 
50
.  
Secondly, besides their well-known function in energy metabolism, calcium homeostasis, production of 
reactive oxygen species (ROS) and apoptosis, mitochondria play an essential role in regulating 
neurogenesis and neuronal plasticity 
51
. Disruption of mitochondrial protein translation in Drosophila 
neurons, reduced dendritic arborization, but axon morphology remained relatively unchanged 
52
, which is 
similar to the aberrant pyramidal neuronal morphology observed in female Brd1
+/-
 mice 
14
. The 
differences in fold change ratios of mitochondrial proteins between cell lysate and synaptosome 
purification from the same brain region that we find in the present study could be indicative for altered 
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mitochondrial morphology in female Brd1
+/-
 mice, as the filtration steps during the synaptosome 
preparation favor the extraction of smaller mitochondria. Interestingly, presynaptic mitochondrial 
morphology has been shown to correlate with impaired working memory in monkey brain 
53
. Moreover, 
the mitochondrial apoptotic pathway can be moderately and locally activated to induce LTD, resulting in 
shrinkage and loss of dendritic spines in the absence of cell death 
54,55
. This system as well as 
mitochondria morphological changes are sensitive to sublethal mitochondrial stress 
55,56
, which can be 
induced by excess of Ca
2+
 through disinhibition of glutamate release as a result of GABAergic 
dysfunction or by loss of Ca
2+ 
buffering capacity through
 
loss of parvalbumin 
57
, both observed in Brd1
+/-
 
mice 
9
. Finally, mitochondrial function has been shown to be linked to synaptic plasticity, cell resilience 
and psychiatric phenotypes 
58,59
. Mitochondrial genes are in fact significantly enriched among the 108 
schizophrenia genome-wide associated loci 
60
 and psychiatric disorders are comorbid to mitochondrial 
dysfunction and can be diagnosed years before any symptoms of mitochondrial disease 
61,62
.  
When we investigated dendritic spine morphology in aCC from female Brd1
+/-
 mice, we found that 
reduced Brd1 levels coincide with a loss of the mature mushroom-type and an increase of the immature 
stubby spines 
63
. Furthermore, dendritic spines in Brd1
+/-
 mice are generally smaller, and this is especially 
pronounced in the small spines subgroup. Whereas the spine head size is directly correlated to the post 
synaptic density size, presynaptic vesicle amount 
64
 and postsynaptic receptor abundance 
65,66
, reduced 
neck and ground diameter have been shown to greatly limit the signal transduction and diffusion rates of 
molecules into the dendritic shaft 
65,67
. Under normal circumstances, small spines with thin necks are 
more likely to limit efflux from the spine head and, hereby making them more optimized for selective 
induction of long term potentiation (LTP) 
65
, and large spines are more resistant to LTP hereby securing 
memory formation 
68
. On the other hand, Ca
2+
 spread from the dendritic spine into the dendritic shaft and 
neighboring spines contributes to the potentiation and stabilization of co-active spines during 
development of the brain 
69
. Similarly, in the adult brain Rho GTPases can diffuse to neighboring spines 
and change the conditions for LTP or long term depression (LTD) locally, greatly influencing the 
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establishment and maintenance of neuronal networks 
70,71
. The smaller spines could therefore suggest 
memory formation impairments as observed in both male and female Brd1
+/-
 mice 
9,14,18
.  
Conclusion 
In summary, we show that reduced BRD1 levels have widespread effects on protein abundancies and 
compartmentalization in mouse brain regions. Further linking the actions of BRD1 to psychiatric 
disorders, we find that affected proteins in frontal cortex and hippocampus are enriched for schizophrenia 
risk. Our study also principally corroborate previous indications from RNAseq studies in Brd1
+/-
 mice 
that reduced Brd1 expression in mouse brain might disturb mitochondrial function and cytoskeletal 
organization, both of which have been shown to play a role in neuromorphology, as well as density and 
morphology of spines. Lastly, we show that female Brd1
+/- 
mice display reduced dendritic spine size, 
which is likely to affect memory formation and inhibit clustered spine plasticity, affecting brain network 
formation and information processing. Future studies using for example two photon microscopy 
investigating live spine response to stimuli and the effect of malformed spines on spine crosstalk could 
supplement our data and help us identify the role of BRD1 in these brain processes.  
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
Legends Suppl. Tables (online) 
Suppl. Table 1: GO cellular component annotation for unique proteins from synaptosomal and cell lysate 
preparations. Green: p<0.05.  
 
Suppl. Table 2: Overview of all proteins per brain region and purification method. Statistical significance 
according to PLGEM 
23,24
. Marked in red: p<0.05. Marked in green: LFC > cut-off. Marked in orange: 
LFC < -cut-off. 
 
Suppl. Table 3-4: see suppl. Information 
 
Suppl. Table 5: Overview of DAVID Annotation Cluster analysis. Disease, function and keyword and 
other annotations are included according to standard settings of DAVID Annotation Clustering. A Cluster 
is defined as a group of terms having similar biological meaning due to sharing similar gene or protein 
members. Statistical enrichment is calculated by the EASE Score, a modified Fisher Exact P-value. The 
Group Enrichment Score is calculated as the geometric mean (in –log10 scale) of member's P-values in a 
corresponding annotation cluster. List Total = number of genes in the gene list. Population (Pop) Hits = 
number of genes in the total group of genes assayed that belong to the specific Gene Category. Population 
(Pop) Total = number of genes in the total group of genes assayed that belong to any Gene Category 
within the System.  
 
Suppl. Table 6: Overview of enrichment for transcription factor binding. P-values are calculated by 
Fisher's exact test and corrected for multiple testing by the BH method.  
 
Suppl. Table 7: Overview of DCPs per brain region. Synaptosomal-to-cell lysate abundant ratios 
(syn/cell) are calculated for each sample and compared between genotypes using PLGEM. DCPs are 
identified when p<0.05 and LFC<0. Marked in red: p<0.05. Marked in green: LFC > cut-off. Marked in 
orange: LFC < -cut-off. 
 
Suppl. Table 8: Overview of dendritic spine morphology parameter calculations.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
Acknowledgements  
This study was funded by the Lundbeck Foundation, Denmark (grant number R155-2014-1724) (ADB), 
The Novo Nordisk Foundation (ADB & JHC), The Danish Council for Independent Research–Medical 
Sciences (ADB and JHC), Aarhus University (ADB) and John and Birthe Meyer Foundation (JhP). 
Centre for Stochastic Geometry and Advanced Bioimaging is supported by Villum Foundation. The 
funders had no involvement in any aspect of the study.  
We thank Anne Hedemand (Aarhus University) and Tanja Østergaard (Aarhus University) for genotyping 
of mice, Margrethe Kjeldsen (Aarhus University Hospital) and Tanja Østergaard (Aarhus University) for 
assistance with Western Blotting and Abdel-Rahman Al-Absi (Aarhus University Hospital) for assistance 
with dendritic spine morphology analysis.  
Contributions 
VP, MS, APR, GW, JRN, JhP, ADB, JHC designed and directed experiments. VP, MS, APR collected 
samples and data. VP, MS, AVE, EAE, JhP analysed mass spectrometry results. VP, MS, APR, JG, JhP, 
ADB, JHC performed statistical analysis. JnP performed MAGMA analysis. VP, APR, JG, GW, JRN, 
JHC designed, performed and analysed spine morphology experiments. VP, MS, PQ, TF, JhP, ADB, JHC 
interpreted results. VP wrote the first draft of the manuscript. All authors contributed to the finalization of 
the manuscript. 
Conflict of interest 
OM and ADB are co-inventors on a patent application submitted by Aarhus University entitled “Method 
for diagnosis and treatment of a mental disease” (EP2287340) that includes claims relating to BRD1 
among other genes. OM, ADB, JHC, APR, and PQ are coinventors on a patent application submitted by 
Capnova A/S entitled “Genetically modified non-human mammal and uses thereof” 
(PCT/EP2013/069524) that includes the Brd1
+/-
 mouse.  
The other authors declare no conflict of interest.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
References 
1  Nyegaard M, Severinsen JE, Als TD, Hedemand A, Straarup S, Nordentoft M et al. Support of association between BRD1 and both 
schizophrenia and bipolar affective disorder. Am J Med Genet Part B Neuropsychiatr Genet 2010; 153: 582–591. 
2  Severinsen JE, Bjarkam CR, Kiaer-Larsen S, Olsen IM, Nielsen MM, Blechingberg J et al. Evidence implicating BRD1 with brain 
development and susceptibility to both schizophrenia and bipolar affective disorder. Mol Psychiatry 2006; 11: 1126–1138. 
3  Aberg K a, Liu Y, Bukszár J, McClay JL, Khachane AN, Andreassen O a et al. A comprehensive family-based replication study of 
schizophrenia genes. JAMA psychiatry 2013; 70: 573–81. 
4  Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P et al. A polygenic burden of rare disruptive mutations in 
schizophrenia. Nature 2014; 506: 185–90. 
5  Jorgensen TH, Børglum  a. D, Mors O, Wang  a. G, Pinaud M, Flint TJ et al. Search for common haplotypes on chromosome 22q in 
patients with schizophrenia or bipolar disorder from the Faroe Islands. Am J Med Genet - Neuropsychiatr Genet 2002; 114: 245–52. 
6  Andreassen OA, Thompson WK, Dale AM. Boosting the power of schizophrenia genetics by leveraging new statistical tools. Schizophr 
Bull 2014; 40: 13–7. 
7  Pardiñas AF, Holmans P, Pocklington AJ, Escott-Price V, Ripke S, Carrera N et al. Common schizophrenia alleles are enriched in 
mutation-intolerant genes and maintained by background selection. 2016. doi:10.1101/068593. 
8  Ripke S, Neale BM, Corvin A, Walters JTR, Farh K-H, Holmans PA et al. Biological insights from 108 schizophrenia-associated 
genetic loci. Nature 2014; 511: 421–427. 
9  Qvist P, Christensen JH, Vardya I, Rajkumar AP, Mørk A, Paternoster V et al. The Schizophrenia-Associated BRD1 Gene Regulates 
Behavior, Neurotransmission, and Expression of Schizophrenia Risk Enriched Gene Sets in Mice. Biol Psychiatry 2016. 
doi:10.1016/j.biopsych.2016.08.037. 
10  Dyrvig M, Qvist P, Lichota J, Larsen K, Nyegaard M, Børglum AD et al. DNA Methylation Analysis of BRD1 Promoter Regions and 
the Schizophrenia rs138880 Risk Allele. PLoS One 2017; 12: e0170121. 
11  Lek M, Karczewski KJ, Minikel E V., Samocha KE, Banks E, Fennell T et al. Analysis of protein-coding genetic variation in 60,706 
humans. Nature 2016; 536: 285–291. 
12  Fryland T , Christensen JH, Pallesen J, Mattheisen M, Palmfeldt J, Bak M et al. Identification of the BRD1 interaction network and its 
impact on mental disorder risk. Genome Med 2016; 8: 53. 
13  Mishima Y, Miyagi S, Saraya A, Negishi M, Endoh M, Endo T  a. et al. The Hbo1-Brd1/Brpf2 complex is responsible for global 
acetylation of H3K14 and required for fetal liver erythropoiesis. Blood 2011; 118: 2443–2453. 
14  Rajkumar AP, Qvist P, Larsen SH, Lazarus R, Pallesen J, Nava N et al. The behavioral and neurobiological effects of reduced Brd1 
expression in mice are sex-biased and implicate gender dependent dysregulation of nuclear receptor mediated signaling in mental  
disorders. bioRxiv 2018; : 257170. 
15  Cho HI, Kim MS, Jang YK. The BRPF2/BRD1-MOZ complex is involved in retinoic acid-induced differentiation of embryonic stem 
cells. Exp Cell Res 2016; 346. doi:10.1016/j.yexcr.2016.05.022. 
16  Christensen JH, Elfving B, Müller HK, Fryland T, Nyegaard M, Corydon TJ et al. The Schizophrenia and Bipolar Disorder associated 
BRD1 gene is regulated upon chronic restraint stress. Eur Neuropsychopharmacol 2012; 22: 651–656. 
17  Fryland T , Elfving B, Christensen JH, Mors O, Wegener G, Børglum AD. Electroconvulsive seizures regulates the Brd1 gene in the 
frontal cortex and hippocampus of the adult rat. Neurosci Lett 2012; 516: 110–113. 
18  Qvist P, Rajkumar AP, Redrobe JP, Nyegaard M, Christensen JH, Mors O et al. Mice heterozygous for an inactivated allele of the 
schizophrenia associated Brd1 gene display selective cognitive deficits with translational relevance to schizophrenia. Neurobiol Learn 
Mem  2017; 141: 44–52. 
19  Qvist P, Eskildsen SF, Hansen B, Baragji M, Ringgaard S, Roovers J et al. Brain volumetric alterations accompanied with loss of 
striatal medium-sized spiny neurons and cortical parvalbumin expressing interneurons in Brd1+/− mice. Sci Rep 2018; 8: 16486. 
20  Chang JW, Arnold MM, Rozenbaum A, Caputo A, Schweizer FE, Huynh M et al. Synaptoneurosome micromethod for fractionation of 
mouse and human brain, and primary neuronal cultures. J Neurosci Methods 2012; 211: 289–295. 
21  Brosch M, Yu L, Hubbard T , Choudhary J. Accurate and sensitive peptide identification with Mascot Percolator. J Proteome Res 2009; 
8: 3176–81. 
22  Polpitiya AD, Qian W-JJ, Jaitly N, Petyuk V a., Adkins JN, Camp DG et al. DAnTE: A statistical tool for quantitative analysis of -
omics data. Bioinformatics 2008; 24: 1556–1558. 
23  Pavelka N, Fournier ML, Swanson SK, Pelizzola M, Ricciardi-Castagnoli P, Florens L et al. Statistical similarities between 
transcriptomics and quantitative shotgun proteomics data. Mol Cell Proteomics 2008; 7: 631–644. 
24  Pavelka N, Pelizzola M, Vizzardelli C, Capozzoli M, Splendiani A, Granucci F et al. A power law global error model for the 
identification of differentially expressed genes in microarray data. BMC Bioinformatics 2004; 5: 203. 
25  Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong S-E et al. A mitochondrial protein compendium elucidates complex I 
disease biology. Cell 2008; 134: 112–23. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
26  Smith AC, Blackshaw JA, Robinson AJ. MitoMiner: a data warehouse for mitochondrial proteomics data. Nucleic Acids Res 2012; 40: 
D1160-7. 
27  Mudunuri U, Che A, Yi M, Stephens RM. bioDBnet: the biological database network. Bioinformatics 2009; 25: 555–6. 
28  Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. 
Nat Protoc 2009; 4: 44–57. 
29  Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J et al. STRING v10: protein-protein interaction 
networks, integrated over the tree of life. Nucleic Acids Res 2015; 43: D447-52. 
30  Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV et al. Enrichr: interactive and collaborative HTML5 gene list  enrichment 
analysis tool. BMC Bioinformatics 2013; 14: 128. 
31  de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol 2015; 
11: e1004219. 
32  Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C et al. Meta-analysis of 74,046 individuals identifies 11 
new susceptibility loci for Alzheimer’s disease. Nat Genet 2013; 45: 1452–8. 
33  Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke S, Wray NR, Lewis CM, Hamilton SP, 
Weissman MM et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 2013; 18: 
497–511. 
34  Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiat ric 
disorders: a genome-wide analysis. Lancet 2013; 381: 1371–9. 
35  Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder 
identifies a new susceptibility locus near ODZ4. Nat Genet 2011; 43: 977–83. 
36  Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S et al. Defining the role of common variation in the genomic and 
biological architecture of adult human height. Nat Genet 2014; 46: 1173–86. 
37  Demontis D, Walters RK, Martin J, Mattheisen M, Als TD, Agerbo E et al. Discovery Of The First Genome-Wide Significant Risk 
Loci For ADHD. bioRxiv 2017; : 145581. 
38  Grove J, Ripke S, Als TD, Mattheisen M, Walters R, Won H et al. Common risk variants identified in autism spectrum disorder. 
bioRxiv 2017; : 224774. 
39  1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM et al. An integrated map of genetic 
variation from 1,092 human genomes. Nature 2012; 491: 56–65. 
40  Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest: Tests in Linear Mixed Effects models. 2016.  
41  Paternoster V, Rajkumar AP, Nyengaard JR, Børglum AD, Grove J, Christensen JH. The importance of data structure in statistical 
analysis of dendritic spine morphology. J Neurosci Methods 2017; 296: 93–98. 
42  Penazzi L, Bakota L, Brandt R. Microtubule Dynamics in Neuronal Development, Plasticity, and Neurodegeneration. Int Rev Cell Mol 
Biol 2016; 321: 89–169. 
43  Dent EW. Of microtubules and memory: implications for microtubule dynamics in dendrites and spines. Mol Biol Cell 2017; 28: 1–8. 
44  English JA, Pennington K, Dunn MJ, Cotter DR. The neuroproteomics of sch izophrenia. Biol Psychiatry 2011; 69: 163–72. 
45  Saia‑ cereda VM, Cassoli JS, Martins‑ de‑ souza D, Nascimento JM. Psychiatric disorders biochemical pathways unraveled by human 
brain proteomics. Eur Arch Psychiatry Clin Neurosci 2017; 267: 3–17. 
46  Davalieva K, Maleva Kostovska I, Dwork AJ. Proteomics Research in Schizophrenia. Front Cell Neurosci 2016; 10: 18. 
47  Sidoli S, Kulej K, Garcia BA. Why proteomics is not the new genomics and the future of mass spectrometry in cell biology. J Cell Biol 
2016. doi:10.1083/jcb.201612010. 
48  Jaworski J, Kapitein LC, Gouveia SM, Dortland BR, Wulf PS, Grigoriev I et al. Dynamic Microtubules Regulate Dendritic Spine 
Morphology and Synaptic Plasticity. Neuron 2009; 61: 85–100. 
49  Segu L, Pascaud A, Costet P, Darmon M, Buhot M-C. Impairment of spatial learning and memory in ELKL Motif Kinase1 
(EMK1/MARK2) knockout mice. Neurobiol Aging 2008; 29: 231–40. 
50  Shelton MA, Newman JT , Gu H, Sampson AR, Fish KN, MacDonald ML et al. Loss of Microtubule-Associated Protein 2 
Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia. Biol Psychiatry 2015; 78. doi:10.1016/j.biopsych.2014.12.029. 
51  Morava E, Kozicz T . Mitochondria and the economy of stress (mal)adaptation. Neurosci Biobehav Rev 2013; 37: 668–80. 
52  Chihara T , Luginbuhl D, Luo L. Cytoplasmic and mitochondrial protein translation in axonal and dendritic terminal arborization.  Nat 
Neurosci 2007; 10: 828–37. 
53  Hara Y, Yuk F, Puri R, Janssen WGM, Rapp PR, Morrison JH. Presynaptic mitochondrial morphology in monkey prefrontal cortex 
correlates with working memory and is improved with estrogen treatment. Proc Natl Acad Sci U S A 2014; 111: 486–91. 
54  Sheng M, Ertürk A. Long-term depression: a cell biological view. Philos Trans R Soc Lond B Biol Sci 2014; 369: 20130138. 
55  D’Amelio M, Cavallucci V, Middei S, Marchetti C, Pacioni S, Ferri A et al. Caspase-3 triggers early synaptic dysfunction in a mouse 
model of Alzheimer’s disease. Nat Neurosci 2011; 14: 69–76. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
56  Barbour JA, Turner N. Mitochondrial stress signaling promotes cellular adaptations. Int J Cell Biol 2014; 2014: 156020. 
57  Davis J, Moylan S, Harvey BH, Maes M, Berk M. Neuroprogression in schizophrenia: Pathways underpinning clinical staging and 
therapeutic corollaries. Aust New Zeal J Psychiatry 2014; 48: 512–529. 
58  Manji H, Kato T, Di Prospero N a., Ness S, Beal MF, Krams M et al. Impaired mitochondrial function in psychiatric disorders. Nat Rev 
Neurosci 2012; 13: 293–307. 
59  Palmfeldt J, Henningsen K, Eriksen SA, Müller HK, Wiborg O. Protein biomarkers of susceptibility and resilience to stress in a rat 
model of depression. Mol Cell Neurosci 2016; 74: 87–95. 
60  Hjelm BE, Rollins B, Mamdani F, Lauterborn JC, Kirov G, Lynch G et al. Evidence of Mitochondrial Dysfunction within the Complex 
Genetic Etiology of Schizophrenia. Mol neuropsychiatry 2015; 1: 201–19. 
61  Anglin RE, Tarnopolsky MA, Mazurek MF, Rosebush PI. The psychiatric presentation of mitochondrial disorders in adults. J 
Neuropsychiatry Clin Neurosci 2012; 24: 394–409. 
62  Fattal O, Link J, Quinn K, Cohen BH, Franco K. Psychiatric comorbidity in 36 adults with mitochondrial cytopathies. CNS Spectr 
2007; 12: 429–38. 
63  Qiao H, Li M-X, Xu C, Chen H-B, An S-C, Ma X-M et al. Dendritic Spines in Depression: What We Learned from Animal Models. 
Neural Plast 2016; 2016: 1–26. 
64  Harris ’ KM, Stevens JK, Harris KM. Dendritic Spines of CA1 Pyramidal Cells in the Rat Hippocampus: Serial Electron Microscop y 
with Reference to Their Biophysical Characteristics. J Neurosci 1989; : 2982–2997. 
65  Noguchi J, Matsuzaki M, Ellis-Davies GCR, Kasai H. Spine-neck geometry determines NMDA receptor-dependent Ca2+ signaling in 
dendrites. Neuron 2005; 46: 609–22. 
66  Matsuzaki M, Ellis-Davies GCR, Nemoto T, Miyashita Y, Iino M, Kasai H. Dendritic spine geometry is critical for AMPA receptor 
expression in hippocampal CA1 pyramidal neurons. Nat Neurosci 2001; 4: 1086–1092. 
67  Ramirez SA, Raghavachari S, Lew DJ. Dendritic spine geometry can localize GTPase signaling in neurons. Mol Biol Cell 2015; 26: 
4171–81. 
68  Matsuzaki M, Honkura N, Ellis-Davies GCR, Kasai H. Structural basis of long-term potentiation in single dendritic spines. Nature 
2004; : 761–766. 
69  Lee KFH, Soares C, Thivierge J-P, Béïque J-C. Correlated Synaptic Inputs Drive Dendritic Calcium Amplification and Cooperative 
Plasticity during Clustered Synapse Development. Neuron 2016; 89: 784–799. 
70  Govindarajan A, Israely I, Huang S-Y, Tonegawa S. The Dendritic Branch Is the Preferred Integrative Unit for Protein Synthesis-
Dependent LTP. Neuron 2011; 69: 132–146. 
71  van Bommel B, Mikhaylova M. Talking to the neighbours: The molecular and physiological mechanisms of clustered synaptic 
plasticity. Neurosci Biobehav Rev 2016; 71: 352–361. 
 
  
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
Highlights 
 Differentially abundant proteins could be identified in frontal cortex, hippocampus and striatum of Brd1+/- mice.  
 Differentially abundant proteins are enriched for proteins involved in cytoskeleton dynamics and mitochondria.  
 Reduced Brd1 expression affects proteins encoded by schizophrenia risk genes. 
 Brd1+/- mice have less mature mushroom-type and more immature stubby-type dendritic spines.  
 Small dendritic spines are even smaller in Brd1+/- mice. 
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